✦ LIBER ✦

Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation

✍ Scribed by Pfeiffenberger, Jan; Koschny, Ronald; Hoffmann, Katrin; Mehrabi, Arianeb; Schmitz, Anne; Radeleff, Boris; Stremmel, Wolfgang; Schemmer, Peter; Ganten, Tom M.

Book ID: 121598861
Publisher: Springer
Year: 2013
Tongue: English
Weight: 133 KB
Volume: 398
Category: Article
ISSN: 1435-2451
DOI: 10.1007/s00423-013-1114-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib for the Treatment of Recurrent

Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?

✍ Vitale, A.; Boccagni, P.; Kertusha, X.; Zanus, G.; D'Amico, F.; Lodo, E.; Pastor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Treatment of recurrent hepatocellular ca

Treatment of recurrent hepatocellular carcinoma after liver transplantation

✍ Hye Ryun KIM; Seong Ha CHEON; Sun Young RHA; Soohyeon LEE; Kwang-Hyub HAN; Chae 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Treatment of recurrent hepatocellular ca

Treatment of recurrent hepatocellular carcinoma after liver transplantation

✍ Eric Davis; Russell Wiesner; Juan Valdecasas; Yoshiaki Kita; Massimo Rossi; Myro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

573 SURVIVAL AND RECURRENCE OF HEPATOCEL

573 SURVIVAL AND RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANT

✍ B. Mitlyng; C. Smith 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy and Safety of Combination Thera

Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation

✍ De Simone, P.; Crocetti, L.; Pezzati, D.; Bargellini, I.; Ghinolfi, D.; Carrai, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Impact of pretransplantation transarteri

Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma

✍ Thomas Decaens; Françoise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-